These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7690312)

  • 1. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
    Invitti C; Pecori Giraldi F; Tagliaferri A; Scacchi M; Dubini A; Cavagnini F
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):213-6. PubMed ID: 7690312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin positively modulates prolactin secretion in normal women.
    Grottoli S; Arvat E; Gianotti L; Ramunni J; Di Vito L; Maccagno B; Ciccarelli E; Camanni F; Ghigo E
    J Endocrinol Invest; 1996 Dec; 19(11):739-44. PubMed ID: 9061507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease.
    Giustina A; Bossoni S; Bussi AR; Pozzi A; Wehrenberg WB
    Endocr Res; 1993 Mar; 19(1):47-56. PubMed ID: 7681769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of prolactin secretion in patients with Cushing's disease. A comparative study on the effects of dexamethasone, lysine vasopressin and ACTH on prolactin secretion by the rat pituitary gland in vitro.
    Lamberts SW; de Quijada M; Visser TJ
    Neuroendocrinology; 1981 Mar; 32(3):150-4. PubMed ID: 6261178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
    Leal-Cerro A; Soto A; Martínez MA; Alvarez P; Isidro L; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.
    Grottoli S; Arvat E; Gauna C; Maccagno B; Ramunni J; Giordano R; Maccario M; Deghenghi R; Ghigo E
    Pituitary; 1999 Nov; 2(3):197-204. PubMed ID: 11081154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
    Röjdmark S; Carlsson A
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
    Comtois R; Beauregard H; Hardy J; Robert F; Somma M
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):7-16. PubMed ID: 3928213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin are secreted more irregularly in patients with Cushing's disease.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2000 May; 52(5):625-32. PubMed ID: 10792343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man.
    Ghigo E; Maccario M; Arvat E; Valetto MR; Valente F; Nicolosi M; Mazza E; Martina V; Cocchi D; Camanni F
    Metabolism; 1992 Jan; 41(1):85-9. PubMed ID: 1371576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anterior pituitary responsiveness in central Cushing disease and in Cushing syndrome caused by adrenal cortex tumors, as well as in simple obesity].
    Góth M; Szabolcs I; Kovács Z; Szilágyi G
    Orv Hetil; 1995 Jan; 136(2):63-6. PubMed ID: 7862432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metoclopramide on the growth hormone response to galanin in normal man.
    Giustina A; Bussi AR; Doga M; Licini M; Schettino M; Wehrenberg WB
    Horm Metab Res; 1993 Sep; 25(9):489-92. PubMed ID: 7693566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F; Invitti C; Cavagnini F;
    Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.